California Cancer Reporting System Standards, Volume III
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
Primary Site [NAACCR #400]
EOD--Extension [NAACCR #790]
Histologic Type ICD-O-3 [NAACCR #522]
EOD--Lymph Node Involv [NAACCR #810]
Over-ride Site Stage [NAACCR #2220]
IF 363: Conflict among Primary Site [value], Histologic Type ICD-O-3 [value], EOD--Extension [value], EOD--Lymph Node Involv [value], and Over-ride Site Stage [value]
If Primary Site = 069, 189 (and Histologic Type ICD-O-3 <> 8220), 260-269, 390-399, 409, 419, 479, 499, 579, 639, 689, 760-768, then
If EOD--Extension = 10-30 and Lymph Node Involv = 0, then
Over-ride Site Stage (bypass flag in Pos. 14) = 1 else (Err #363)
If Primary Site = 559, then
If EOD--Extension < = 40 and Lymph Node Involv = 0, then
Over-ride Site Stage (bypass flag in Pos. 14) = 1 else (Err #363).
| 2910 | Data Changes: CCR names (Extension, Hist Type 3, Nodes Involved, OR Site Stage, Site) changed to match NAACCR names. |
| 2/7/12 | Changed name back to "Prim Site, Extension, LN Involv" . It should not have been changed in 2010. |